Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 | 64947147 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
1.000 | 0.120 | 1 | 64868174 | non coding transcript exon variant | G/C | snv | 0.39 |
|
Eye Diseases; Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.360 | 1 | 64837655 | intron variant | A/G | snv | 0.37 |
|
Eye Diseases; Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 1 | 64880504 | intron variant | C/T | snv | 0.35 |
|
Infections | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.200 | 1 | 64873549 | 3 prime UTR variant | A/G | snv | 1.0E-02 | 3.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
1 | 65063072 | intron variant | T/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1 | 65066068 | intron variant | A/G | snv | 0.38 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.851 | 0.120 | 1 | 64846735 | missense variant | G/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.200 | 1 | 64873549 | 3 prime UTR variant | A/G | snv | 1.0E-02 | 3.6E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 1 | 65058899 | intron variant | C/G;T | snv | 0.65 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 1 | 65058899 | intron variant | C/G;T | snv | 0.65 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2012 | 2017 | |||||||
|
1.000 | 0.080 | 1 | 64833868 | 3 prime UTR variant | -/TTAA;TTAATTAA | delins |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 1 | 64877383 | intron variant | A/G | snv | 0.16 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 64884439 | intron variant | A/G | snv | 0.43 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 64883925 | intron variant | A/G | snv | 0.37 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 64883861 | intron variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 1 | 64875884 | 3 prime UTR variant | C/T | snv | 0.15 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.763 | 0.120 | 1 | 64846664 | missense variant | C/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.120 | 1 | 64846735 | missense variant | G/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.040 | 1 | 64969742 | intron variant | C/G | snv | 0.18 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.280 | 1 | 64837448 | intron variant | G/T | snv | 5.1E-02 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2012 | 2012 |